These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38487836)

  • 1. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.
    Li S; Xu C; Hu S; Lai J
    Eur Psychiatry; 2024 Mar; 67(1):e29. PubMed ID: 38487836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
    BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
    Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.
    DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
    Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
    J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
    Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
    Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Ikuta T; Sakuma K; Matsuda Y; Iwata N
    J Psychiatr Res; 2019 Aug; 115():121-128. PubMed ID: 31128502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
    Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
    J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    Derry S; Moore RA
    BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and network meta-analysis on comparative efficacy, acceptability, and safety of treatments in acute bipolar mania in youths.
    Tural Hesapcioglu S; Kasak M; Abursu H; Kafali S; Ceylan MF; Akyol M
    J Affect Disord; 2024 Mar; 349():438-451. PubMed ID: 38211745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis.
    Kishi T; Ikuta T; Matsuda Y; Iwata N
    Neuropsychopharmacol Rep; 2019 Sep; 39(3):256-259. PubMed ID: 31283865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.